PT Quantum Clovera Investama Tbk carries a market capitalization of 218.45B, placing it among publicly traded companies globally. Its enterprise value stands at 2.29T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 218.45B |
| Enterprise Value | 2.29T |
PT Quantum Clovera Investama Tbk currently has 18.20B shares outstanding.
| Shares Outstanding | 18.20B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.07, and the price-to-book ratio stands at 1.16.
| PE Ratio | N/A |
| PS Ratio | 0.07 |
| PB Ratio | 1.16 |
| P/TBV Ratio | 0.16 |
| P/FCF Ratio | 4.32 |
| P/OCF Ratio | N/A |
| EV / Sales | 0.56 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 33.91 |
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | 18.19 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
| Return on Equity (ROE) | -47.51 |
| Return on Assets (ROA) | -5.64 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
| Income Tax | 5.35B |
| Effective Tax Rate | N/A |
PT Quantum Clovera Investama Tbk's stock has gained approximately 33.33333% over the past 52 weeks. The 50-day moving average sits at 14.32, while the 200-day moving average is 18.33.
| Beta (5Y) | N/A |
| 52-Week Price Change | 33.33333% |
| 50-Day Moving Average | 14.32 |
| 200-Day Moving Average | 18.33 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, PT Quantum Clovera Investama Tbk generated 4.11T in revenue and converted that into -156.15B in net income, yielding earnings per share of -11.53.
| Revenue | 4.11T |
| Gross Profit | N/A |
| Operating Income | N/A |
| Pretax Income | -204.58B |
| Net Income | -156.15B |
| EBITDA | N/A |
| EBIT | N/A |
| Earnings Per Share (EPS) | -11.53 |
PT Quantum Clovera Investama Tbk holds 137.25B in cash and equivalents against 328.56B in total debt, resulting in a net debt position of -137.25B.
| Cash & Cash Equivalents | 137.25B |
| Total Debt | 328.56B |
| Net Debt | -137.25B |
| Equity (Book Value) | 250.38B |
| Book Value Per Share | 13.75 |
| Working Capital | N/A |
After subtracting -67.42B in capital expenditures, free cash flow totaled -67.42B - equivalent to -3.70 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -67.42B |
| Free Cash Flow | -67.42B |
| FCF Per Share | -3.70 |
PT Quantum Clovera Investama Tbk operates with a gross margin of 100.00, reflecting its pricing power and cost economics.
| Gross Margin | 100.00 |
| Operating Margin | N/A |
| Pretax Margin | -4.97 |
| Profit Margin | -3.80 |
| EBITDA Margin | N/A |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -10.40 |
| FCF Yield | 23.15 |
PT Quantum Clovera Investama Tbk's most recent stock split took place on June 23, 2016 with a 1:5 split ratio.
| Last Split Date | 6/23/2016 |
| Split Ratio | 1:5 |
PT Quantum Clovera Investama Tbk posts an Altman Z-Score of 1.88, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.88 |